Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
about
Effects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft toleranceHuman prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockadeIndoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators.Heme oxygenase-1 in pregnancy and cancer: similarities in cellular invasion, cytoprotection, angiogenesis, and immunomodulation.Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulationCD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.Hsps are up-regulated in melanoma tissue and correlate with patient clinical parameters.Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy.Therapeutic cancer vaccines in combination with conventional therapy.T regulatory cells in cancer: recent advances and therapeutic potential.Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer.The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase.Monitoring regulatory immune responses in tumor immunotherapy clinical trials.Induced regulatory T cells in inhibitory microenvironments created by cancer.Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.Heme oxygenase-1: emerging target of cancer therapy.Suppression of heme oxygenase-1 activity reduces airway hyperresponsiveness and inflammation in a mouse model of asthma.The pharmacological features of bilirubin: the question of the century.Anti-regulatory T cells.Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequenciesCD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer.PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine.CD4 responses against IDO.Characterization of T-cell responses against IκBα in cancer patients.Effector CD4 and CD8 T cells and their role in the tumor microenvironment.Heme oxygenase-1: for better, for worse, in sickness and in health.p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation.Heme oxygenase inhibition in cancers: possible tools and targets.Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAF V600E expression in thyroid cancer.
P2860
Q28084287-41F0B9D0-A692-4F2C-AB0A-C02BB211226DQ34645401-784FA7E4-1F5D-4CFE-91A5-4625214C7185Q34707334-72F9B75C-38EA-4FEE-8C77-B50061FFE733Q34954230-AA9A0598-AD1A-4EFB-84A4-2A05A090AB06Q35408952-F53ECFE9-37FE-4B1A-97C6-1A34310D1B1CQ36179565-FD84C355-0524-4CB8-8F1A-6034AAD5F10CQ36636442-1B7D8769-AF87-4A1F-9F5C-6FD1601BB23CQ36813010-E692C64C-8193-4410-A494-76DAEB14AA68Q37771267-B465EBDE-BD85-44A0-8A51-0FB77BEBCB04Q37800935-8ABE00C8-40A3-40B4-9508-E4B8E75E2477Q37869485-7243CCAE-0E38-4518-8151-F0B339BDC933Q37990434-551758D1-0025-4C26-8F66-27AD87845B2DQ38105081-84F40E04-FC23-4609-9352-61B970F5E17AQ38220701-2E86814E-D957-4ED8-8F64-E2C902AC75D6Q38266251-6F907CB0-9B44-4B33-B73C-DA92A814ADF5Q38426058-992AB364-CE35-408D-888C-86A6C2D55A5EQ38541573-AD5F2809-C419-4D3D-9A24-CE362491873DQ38553611-0B5095F0-0DAB-4CF5-BC8B-FBC8F8F64026Q38817090-34EBC420-6F1D-4F53-8F4C-8889EB4A6619Q39156328-45891879-7DB1-45EA-9FD6-269CF694C05CQ39477283-03C1C651-D64F-4BCD-B784-7D9A8FAA9945Q40966454-A0AF700D-690F-49D2-897A-824F49B2161AQ40994145-565A943E-0C1D-47C4-8386-61A155A17F0EQ41274631-9C49A89D-8191-4422-83FC-C41C0CA294BFQ42403177-0E81E7E8-DB64-4592-8AC7-5382118D9601Q42952683-8A693CA4-0433-4FCB-B7FC-DC2978655636Q43060148-452F4D5C-FDE0-40C6-A8E8-AD3E7B1C7C43Q45122733-66B6B040-DF37-4939-9905-5E7823823FB8Q52431393-A2957177-24AC-43C3-8EF4-271D9A8E369CQ54319067-381BD357-9205-4FAD-9E71-89D9F1944989
P2860
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
@en
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
@nl
type
label
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
@en
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
@nl
prefLabel
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
@en
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
@nl
P2093
P2860
P50
P356
P1476
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients.
@en
P2093
Jürgen C Becker
Marie K Brimnes
Rikke Baek Sørensen
P2860
P304
P356
10.1172/JCI38739
P407
P577
2009-08-01T00:00:00Z